Missed Out on CRISPR Therapeutics? My Best Biotech Stock to Buy and Hold
The market experienced a wild ride in 2022, making investors hesitant to invest in the stock market. However, the S&P 500 appears to have turned the corner this year, rising 17% so far.
In this recovering market, growth stocks that are still undervalued are a good option for risk-averse investors. CRISPR Therapeutics (NASDAQ: CRSP) is a gene-editing biotech company. Let's take a look at why it's not too late to add this stock to your portfolio.
Image source: Getty Images.
Source Fool.com
